nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Meropenem—Renal failure—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Meropenem—Dysuria—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Asthma—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Meropenem—Asthenia—Ifosfamide—testicular cancer	0.000999	0.000999	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—testicular cancer	0.000993	0.000993	CcSEcCtD
Meropenem—Sweating—Methotrexate—testicular cancer	0.00099	0.00099	CcSEcCtD
Meropenem—Feeling abnormal—Cisplatin—testicular cancer	0.000989	0.000989	CcSEcCtD
Meropenem—Paraesthesia—Etoposide—testicular cancer	0.000987	0.000987	CcSEcCtD
Meropenem—Pruritus—Ifosfamide—testicular cancer	0.000985	0.000985	CcSEcCtD
Meropenem—Dyspnoea—Etoposide—testicular cancer	0.00098	0.00098	CcSEcCtD
Meropenem—Somnolence—Etoposide—testicular cancer	0.000978	0.000978	CcSEcCtD
Meropenem—Hepatobiliary disease—Methotrexate—testicular cancer	0.000977	0.000977	CcSEcCtD
Meropenem—Epistaxis—Methotrexate—testicular cancer	0.000974	0.000974	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—testicular cancer	0.000972	0.000972	CcSEcCtD
Meropenem—Nausea—Bleomycin—testicular cancer	0.000968	0.000968	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—testicular cancer	0.000967	0.000967	CcSEcCtD
Meropenem—Infestation—Epirubicin—testicular cancer	0.000967	0.000967	CcSEcCtD
Meropenem—Vomiting—Dactinomycin—testicular cancer	0.000966	0.000966	CcSEcCtD
Meropenem—Agranulocytosis—Methotrexate—testicular cancer	0.000964	0.000964	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000958	0.000958	CcSEcCtD
Meropenem—Rash—Dactinomycin—testicular cancer	0.000958	0.000958	CcSEcCtD
Meropenem—Decreased appetite—Etoposide—testicular cancer	0.000956	0.000956	CcSEcCtD
Meropenem—Diarrhoea—Ifosfamide—testicular cancer	0.000953	0.000953	CcSEcCtD
Meropenem—Renal failure—Epirubicin—testicular cancer	0.00095	0.00095	CcSEcCtD
Meropenem—Gastrointestinal disorder—Etoposide—testicular cancer	0.000949	0.000949	CcSEcCtD
Meropenem—Body temperature increased—Cisplatin—testicular cancer	0.000949	0.000949	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—testicular cancer	0.000947	0.000947	CcSEcCtD
Meropenem—Jaundice—Epirubicin—testicular cancer	0.000942	0.000942	CcSEcCtD
Meropenem—Pain—Etoposide—testicular cancer	0.00094	0.00094	CcSEcCtD
Meropenem—Constipation—Etoposide—testicular cancer	0.00094	0.00094	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—testicular cancer	0.000938	0.000938	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—testicular cancer	0.000938	0.000938	CcSEcCtD
Meropenem—Haemoglobin—Methotrexate—testicular cancer	0.000932	0.000932	CcSEcCtD
Meropenem—Haemorrhage—Methotrexate—testicular cancer	0.000927	0.000927	CcSEcCtD
Meropenem—Hepatitis—Methotrexate—testicular cancer	0.000927	0.000927	CcSEcCtD
Meropenem—Sweating—Epirubicin—testicular cancer	0.000927	0.000927	CcSEcCtD
Meropenem—Dizziness—Ifosfamide—testicular cancer	0.000921	0.000921	CcSEcCtD
Meropenem—Pharyngitis—Methotrexate—testicular cancer	0.00092	0.00092	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—testicular cancer	0.000912	0.000912	CcSEcCtD
Meropenem—Feeling abnormal—Etoposide—testicular cancer	0.000906	0.000906	CcSEcCtD
Meropenem—Nausea—Dactinomycin—testicular cancer	0.000903	0.000903	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—testicular cancer	0.000902	0.000902	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—testicular cancer	0.0009	0.0009	CcSEcCtD
Meropenem—Gastrointestinal pain—Etoposide—testicular cancer	0.000899	0.000899	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—testicular cancer	0.000894	0.000894	CcSEcCtD
Meropenem—Infestation—Doxorubicin—testicular cancer	0.000894	0.000894	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000887	0.000887	CcSEcCtD
Meropenem—Vomiting—Ifosfamide—testicular cancer	0.000885	0.000885	CcSEcCtD
Meropenem—Hypersensitivity—Cisplatin—testicular cancer	0.000884	0.000884	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—testicular cancer	0.000883	0.000883	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—testicular cancer	0.000879	0.000879	CcSEcCtD
Meropenem—Rash—Ifosfamide—testicular cancer	0.000878	0.000878	CcSEcCtD
Meropenem—Dermatitis—Ifosfamide—testicular cancer	0.000877	0.000877	CcSEcCtD
Meropenem—Erythema multiforme—Methotrexate—testicular cancer	0.000877	0.000877	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000877	0.000877	CcSEcCtD
Meropenem—Urticaria—Etoposide—testicular cancer	0.000874	0.000874	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—testicular cancer	0.000872	0.000872	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—testicular cancer	0.000872	0.000872	CcSEcCtD
Meropenem—Body temperature increased—Etoposide—testicular cancer	0.000869	0.000869	CcSEcCtD
Meropenem—Abdominal pain—Etoposide—testicular cancer	0.000869	0.000869	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—testicular cancer	0.000868	0.000868	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—testicular cancer	0.000868	0.000868	CcSEcCtD
Meropenem—Asthenia—Cisplatin—testicular cancer	0.000861	0.000861	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—testicular cancer	0.000861	0.000861	CcSEcCtD
Meropenem—Sweating—Doxorubicin—testicular cancer	0.000857	0.000857	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—testicular cancer	0.000855	0.000855	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—testicular cancer	0.000844	0.000844	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—testicular cancer	0.000837	0.000837	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Meropenem—Chills—Methotrexate—testicular cancer	0.000832	0.000832	CcSEcCtD
Meropenem—Nausea—Ifosfamide—testicular cancer	0.000827	0.000827	CcSEcCtD
Meropenem—Diarrhoea—Cisplatin—testicular cancer	0.000821	0.000821	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—testicular cancer	0.00082	0.00082	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—testicular cancer	0.000817	0.000817	CcSEcCtD
Meropenem—Hypersensitivity—Etoposide—testicular cancer	0.00081	0.00081	CcSEcCtD
Meropenem—Erythema—Methotrexate—testicular cancer	0.000807	0.000807	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—testicular cancer	0.000807	0.000807	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—testicular cancer	0.000803	0.000803	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—testicular cancer	0.000803	0.000803	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—testicular cancer	0.000797	0.000797	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—testicular cancer	0.000791	0.000791	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—testicular cancer	0.00079	0.00079	CcSEcCtD
Meropenem—Asthenia—Etoposide—testicular cancer	0.000789	0.000789	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—testicular cancer	0.000784	0.000784	CcSEcCtD
Meropenem—Back pain—Methotrexate—testicular cancer	0.000781	0.000781	CcSEcCtD
Meropenem—Chills—Epirubicin—testicular cancer	0.000779	0.000779	CcSEcCtD
Meropenem—Pruritus—Etoposide—testicular cancer	0.000778	0.000778	CcSEcCtD
Meropenem—Vomiting—Cisplatin—testicular cancer	0.000763	0.000763	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—testicular cancer	0.000759	0.000759	CcSEcCtD
Meropenem—Rash—Cisplatin—testicular cancer	0.000757	0.000757	CcSEcCtD
Meropenem—Dermatitis—Cisplatin—testicular cancer	0.000756	0.000756	CcSEcCtD
Meropenem—Erythema—Epirubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Meropenem—Diarrhoea—Etoposide—testicular cancer	0.000752	0.000752	CcSEcCtD
Meropenem—Anaemia—Methotrexate—testicular cancer	0.000746	0.000746	CcSEcCtD
Meropenem—Flatulence—Epirubicin—testicular cancer	0.000744	0.000744	CcSEcCtD
Meropenem—Tension—Epirubicin—testicular cancer	0.000741	0.000741	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—testicular cancer	0.00074	0.00074	CcSEcCtD
Meropenem—Nervousness—Epirubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Meropenem—Back pain—Epirubicin—testicular cancer	0.000731	0.000731	CcSEcCtD
Meropenem—Malaise—Methotrexate—testicular cancer	0.000728	0.000728	CcSEcCtD
Meropenem—Dizziness—Etoposide—testicular cancer	0.000727	0.000727	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—testicular cancer	0.000725	0.000725	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—testicular cancer	0.000722	0.000722	CcSEcCtD
Meropenem—Chills—Doxorubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Meropenem—Nausea—Cisplatin—testicular cancer	0.000713	0.000713	CcSEcCtD
Meropenem—Cough—Methotrexate—testicular cancer	0.000704	0.000704	CcSEcCtD
Meropenem—Vomiting—Etoposide—testicular cancer	0.000699	0.000699	CcSEcCtD
Meropenem—Erythema—Doxorubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Meropenem—Anaemia—Epirubicin—testicular cancer	0.000698	0.000698	CcSEcCtD
Meropenem—Agitation—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Meropenem—Rash—Etoposide—testicular cancer	0.000693	0.000693	CcSEcCtD
Meropenem—Dermatitis—Etoposide—testicular cancer	0.000693	0.000693	CcSEcCtD
Meropenem—Headache—Etoposide—testicular cancer	0.000689	0.000689	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Meropenem—Chest pain—Methotrexate—testicular cancer	0.000687	0.000687	CcSEcCtD
Meropenem—Tension—Doxorubicin—testicular cancer	0.000686	0.000686	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—testicular cancer	0.000684	0.000684	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000682	0.000682	CcSEcCtD
Meropenem—Malaise—Epirubicin—testicular cancer	0.000681	0.000681	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Meropenem—Syncope—Epirubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Meropenem—Back pain—Doxorubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Meropenem—Confusional state—Methotrexate—testicular cancer	0.000664	0.000664	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—testicular cancer	0.000664	0.000664	CcSEcCtD
Meropenem—Cough—Epirubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—testicular cancer	0.000659	0.000659	CcSEcCtD
Meropenem—Infection—Methotrexate—testicular cancer	0.000654	0.000654	CcSEcCtD
Meropenem—Nausea—Etoposide—testicular cancer	0.000653	0.000653	CcSEcCtD
Meropenem—Hypertension—Epirubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—testicular cancer	0.000646	0.000646	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—testicular cancer	0.000646	0.000646	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—testicular cancer	0.000645	0.000645	CcSEcCtD
Meropenem—Chest pain—Epirubicin—testicular cancer	0.000643	0.000643	CcSEcCtD
Meropenem—Agitation—Doxorubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Meropenem—Anxiety—Epirubicin—testicular cancer	0.000641	0.000641	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—testicular cancer	0.00064	0.00064	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000639	0.000639	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—testicular cancer	0.000637	0.000637	CcSEcCtD
Meropenem—Malaise—Doxorubicin—testicular cancer	0.00063	0.00063	CcSEcCtD
Meropenem—Anorexia—Methotrexate—testicular cancer	0.000628	0.000628	CcSEcCtD
Meropenem—Syncope—Doxorubicin—testicular cancer	0.000627	0.000627	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Meropenem—Confusional state—Epirubicin—testicular cancer	0.000622	0.000622	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Meropenem—Oedema—Epirubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Meropenem—Hypotension—Methotrexate—testicular cancer	0.000616	0.000616	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Meropenem—Infection—Epirubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Meropenem—Cough—Doxorubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Meropenem—Shock—Epirubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—testicular cancer	0.000605	0.000605	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—testicular cancer	0.000603	0.000603	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—testicular cancer	0.000599	0.000599	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—testicular cancer	0.000596	0.000596	CcSEcCtD
Meropenem—Insomnia—Methotrexate—testicular cancer	0.000596	0.000596	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—testicular cancer	0.000595	0.000595	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—testicular cancer	0.000591	0.000591	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Meropenem—Anorexia—Epirubicin—testicular cancer	0.000588	0.000588	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—testicular cancer	0.000587	0.000587	CcSEcCtD
Meropenem—Somnolence—Methotrexate—testicular cancer	0.000586	0.000586	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—testicular cancer	0.00058	0.00058	CcSEcCtD
Meropenem—Hypotension—Epirubicin—testicular cancer	0.000576	0.000576	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—testicular cancer	0.000575	0.000575	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—testicular cancer	0.000573	0.000573	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—testicular cancer	0.00057	0.00057	CcSEcCtD
Meropenem—Oedema—Doxorubicin—testicular cancer	0.00057	0.00057	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000569	0.000569	CcSEcCtD
Meropenem—Infection—Doxorubicin—testicular cancer	0.000567	0.000567	CcSEcCtD
Meropenem—Pain—Methotrexate—testicular cancer	0.000563	0.000563	CcSEcCtD
Meropenem—Shock—Doxorubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—testicular cancer	0.000559	0.000559	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Meropenem—Insomnia—Epirubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—testicular cancer	0.000551	0.000551	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Meropenem—Somnolence—Epirubicin—testicular cancer	0.000548	0.000548	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—testicular cancer	0.000544	0.000544	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—testicular cancer	0.000543	0.000543	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—testicular cancer	0.000543	0.000543	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—testicular cancer	0.000539	0.000539	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—testicular cancer	0.000536	0.000536	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—testicular cancer	0.000533	0.000533	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Meropenem—Pain—Epirubicin—testicular cancer	0.000527	0.000527	CcSEcCtD
Meropenem—Constipation—Epirubicin—testicular cancer	0.000527	0.000527	CcSEcCtD
Meropenem—Urticaria—Methotrexate—testicular cancer	0.000523	0.000523	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—testicular cancer	0.000521	0.000521	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—testicular cancer	0.000521	0.000521	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—testicular cancer	0.000516	0.000516	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—testicular cancer	0.000512	0.000512	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—testicular cancer	0.000509	0.000509	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—testicular cancer	0.000507	0.000507	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—testicular cancer	0.000504	0.000504	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—testicular cancer	0.000496	0.000496	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Meropenem—Urticaria—Epirubicin—testicular cancer	0.00049	0.00049	CcSEcCtD
Meropenem—Pain—Doxorubicin—testicular cancer	0.000488	0.000488	CcSEcCtD
Meropenem—Constipation—Doxorubicin—testicular cancer	0.000488	0.000488	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—testicular cancer	0.000485	0.000485	CcSEcCtD
Meropenem—Asthenia—Methotrexate—testicular cancer	0.000473	0.000473	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000466	0.000466	CcSEcCtD
Meropenem—Pruritus—Methotrexate—testicular cancer	0.000466	0.000466	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—testicular cancer	0.000454	0.000454	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—testicular cancer	0.000453	0.000453	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—testicular cancer	0.000451	0.000451	CcSEcCtD
Meropenem—Asthenia—Epirubicin—testicular cancer	0.000442	0.000442	CcSEcCtD
Meropenem—Pruritus—Epirubicin—testicular cancer	0.000436	0.000436	CcSEcCtD
Meropenem—Dizziness—Methotrexate—testicular cancer	0.000436	0.000436	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—testicular cancer	0.000422	0.000422	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Meropenem—Vomiting—Methotrexate—testicular cancer	0.000419	0.000419	CcSEcCtD
Meropenem—Rash—Methotrexate—testicular cancer	0.000415	0.000415	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—testicular cancer	0.000415	0.000415	CcSEcCtD
Meropenem—Headache—Methotrexate—testicular cancer	0.000413	0.000413	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—testicular cancer	0.000409	0.000409	CcSEcCtD
Meropenem—Dizziness—Epirubicin—testicular cancer	0.000408	0.000408	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—testicular cancer	0.000404	0.000404	CcSEcCtD
Meropenem—Vomiting—Epirubicin—testicular cancer	0.000392	0.000392	CcSEcCtD
Meropenem—Nausea—Methotrexate—testicular cancer	0.000391	0.000391	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—testicular cancer	0.00039	0.00039	CcSEcCtD
Meropenem—Rash—Epirubicin—testicular cancer	0.000389	0.000389	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Meropenem—Headache—Epirubicin—testicular cancer	0.000386	0.000386	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—testicular cancer	0.000377	0.000377	CcSEcCtD
Meropenem—Nausea—Epirubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—testicular cancer	0.000363	0.000363	CcSEcCtD
Meropenem—Rash—Doxorubicin—testicular cancer	0.00036	0.00036	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—testicular cancer	0.000359	0.000359	CcSEcCtD
Meropenem—Headache—Doxorubicin—testicular cancer	0.000357	0.000357	CcSEcCtD
Meropenem—Nausea—Doxorubicin—testicular cancer	0.000339	0.000339	CcSEcCtD
